Maximus Inc. (MMS)
NYSE: MMS
· Real-Time Price · USD
87.43
-0.91 (-1.03%)
At close: Sep 09, 2025, 3:59 PM
87.42
-0.01%
After-hours: Sep 09, 2025, 06:19 PM EDT
Maximus Revenue Breakdown
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 |
---|---|---|---|
Clinical Services Revenue | 560.36M | 503.96M | 471.53M |
Clinical Services Revenue Growth | +11.19% | +6.88% | n/a |
Technology Solutions Revenue | 79.15M | 88.06M | 89.56M |
Technology Solutions Revenue Growth | -10.12% | -1.68% | n/a |
Revenue by Geography
Period Ending | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Australia Revenue | 30M | 43.59M | 46.67M | 52.81M | 52.83M | 65.28M | 70.95M | 55.93M | 46.77M | 38.41M | 24.54M | 37.44M | 45.68M | 48.74M | 51M | 53.37M |
Australia Revenue Growth | -31.18% | -6.59% | -11.63% | -0.04% | -19.07% | -7.98% | +26.85% | +19.60% | +21.74% | +56.54% | -34.45% | -18.05% | -6.28% | -4.42% | -4.45% | n/a |
Rest Of World Revenue | 37.06M | 47.58M | 51.39M | 43.97M | 45.72M | 50.19M | 37.1M | 34.66M | 26.25M | 22.47M | 27.78M | 28.94M | 27.02M | 26.27M | 26.72M | 26.63M |
Rest Of World Revenue Growth | -22.10% | -7.43% | +16.89% | -3.83% | -8.91% | +35.27% | +7.05% | +32.05% | +16.83% | -19.14% | -3.99% | +7.09% | +2.85% | -1.66% | +0.33% | n/a |
United Kingdom Revenue | 107.11M | 109.78M | 107.9M | 85.81M | 74.66M | 74.11M | 72.88M | 64.79M | 56.25M | 53.36M | 63.72M | 73M | 69.68M | 72.27M | 78.33M | 73.42M |
United Kingdom Revenue Growth | -2.43% | +1.74% | +25.74% | +14.94% | +0.74% | +1.68% | +12.50% | +15.18% | +5.40% | -16.25% | -12.71% | +4.77% | -3.58% | -7.75% | +6.70% | n/a |
United States Revenue | 1B | 924.84M | 971.37M | 968.29M | 932.92M | 1.05B | 778.35M | 790.18M | 794.58M | 787.09M | 702.09M | 678.85M | 612.58M | 583.43M | 580.47M | 511.2M |
United States Revenue Growth | +8.44% | -4.79% | +0.32% | +3.79% | -11.48% | +35.41% | -1.50% | -0.55% | +0.95% | +12.11% | +3.42% | +10.82% | +5.00% | +0.51% | +13.55% | n/a |
Operating Expense Breakdown
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selling, General, and Administrative Revenue | 170.83M | 162.86M | 191.74M | 166.9M | 166.68M | 168.23M | 169.19M | 167.78M | 182.54M | 142.45M | 146.45M | 146.99M | 132.97M | 130.31M | 124.22M | 129.59M | 140.13M | 112.4M | 111.97M | 103.43M | 89.58M | 106.85M | 87.23M | 81.65M | 81.6M | 78.1M | 79.67M | 73.53M | 69.59M | 72.56M | 69.56M | 82.21M | 68.31M | 68.6M | 65.4M | 68.34M | 69.71M | 65.98M | 64.23M | 60.44M | 67M | 59.39M |
Selling, General, and Administrative Revenue Growth | +4.90% | -15.06% | +14.88% | +0.13% | -0.92% | -0.57% | +0.84% | -8.09% | +28.15% | -2.73% | -0.37% | +10.54% | +2.05% | +4.90% | -4.14% | -7.52% | +24.67% | +0.39% | +8.26% | +15.46% | -16.16% | +22.50% | +6.84% | +0.05% | +4.48% | -1.97% | +8.34% | +5.67% | -4.09% | +4.31% | -15.39% | +20.35% | -0.42% | +4.89% | -4.31% | -1.96% | +5.65% | +2.71% | +6.27% | -9.78% | +12.80% | n/a |
Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |